Archives

by in
Entry Author Date Location
Sarepta Drug Helps Boys With Duchenne to Walk; Shares Boom 10/03/12 Boston
Sarepta’s Muscular Dystrophy Drug Improves With Time; Stock Booms 07/24/12 Seattle
N-Gene Digs Up Funds to Boost “Heat Shock” Drug in Diabetes and MD 04/25/12 New York
AVI Biopharma Mulls Deal After Mixed Data With Muscular Dystrophy Drug 04/06/12 Seattle
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug 02/01/10 Seattle
AVI Biopharma Drug Shows Hint of Effect Against Muscular Dystrophy In Small Study 12/22/09 Seattle
AVI Biopharma Settles Into New Digs, Scopes Out Seattle Biotech Talent Pool 09/29/09 Seattle
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News 09/03/09 Seattle
AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain 09/01/09 Seattle
AVI Wins Part of $2.5M Contract 05/06/09 Seattle
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why 10/14/08 Boston
Genzyme, PTC Therapeutics Form Collaboration on Drug For Genetic Diseases 07/17/08 Boston
Page 1 of 1